Wang, H., Peng, R., Wang, J., Qin, Z., & Xue, L. (2018). Circulating microRNAs as potential cancer biomarkers: The advantage and disadvantage. Clin Epigenetics.
Citação norma ChicagoWang, Hao, Ran Peng, Junjie Wang, Zelian Qin, and Lixiang Xue. "Circulating MicroRNAs As Potential Cancer Biomarkers: The Advantage and Disadvantage." Clin Epigenetics 2018.
MLA CitationWang, Hao, et al. "Circulating MicroRNAs As Potential Cancer Biomarkers: The Advantage and Disadvantage." Clin Epigenetics 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.